MENU
ATXS
AS OF
Nov 13, 04:59 PM (EDT)
Price
$12.43
Change
-$0.12 (-0.96%)
Capitalization
708.26M
112 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ATXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Astria Therapeutics (ATXS) Earnings Date & Reports

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ATXS is expected to report earnings to -55 cents per share on March 05

Astria Therapeutics ATXS Stock Earnings Reports
Q4'25
Est.
$-0.55
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.01
The last earnings report on November 12 showed earnings per share of -55 cents, missing the estimate of -41 cents. With 187.97K shares outstanding, the current market capitalization sits at 708.26M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ATXS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATXS showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ATXS
A.I. Advisor
published General Information

General Information

a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 State Street
Phone
+1 617 349-1971
Employees
59
Web
https://www.astriatx.com